Clinical Trials Details

A221805 (Peripheral Neuropathy)

Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study

Objective

The Duloxetine arm of this clinical trial was temporarily suspended  on November 19, 2020. 

Clinical Trial Categories

  • Cancers and Other Neoplasms